INCY options flow: unusual options activity in Incyte Corp.
Updated 28 September 2026, 09:54 ET
Over the last week the tape recorded 5 unusual options prints in Incyte Corp. (INCY), $190K of tracked premium, leaning firmly bullish. Bullish premium was $159K against $32K bearish; $190K went into calls and $0 into puts, a put call ratio of 0.00. The largest print was $66K of INCY 16 Oct 2026 $100 calls on 22 September 2026, swept at ask. The last session with prints, 25 September 2026, added 2 prints and $67K of premium. INCY closed at $123.89 on 25 September 2026, down 0.4%.
This week's unusual flow
Prints from 21 September 2026 to 25 September 2026, 3 sessions. Delayed tier: every print is shown twenty minutes after it executed, and the page is rebuilt after each session.
Net premium is bullish minus bearish premium. The put call ratio is put premium divided by call premium, weighted by money rather than by contract count. Sweeps is the share of prints executed across several exchanges at once. Read the guide: Reading the Pulse.
Largest prints of the week
| Date | Contract | Type | Size | Open int. | Premium | Execution | Sentiment | Tier |
|---|---|---|---|---|---|---|---|---|
| 22 Sep 2026 | INCY 16 Oct 2026 $100 calls | Sweep | 25 | 32 | $66K | At ask | Bullish | Notable |
| 25 Sep 2026 | INCY 20 Nov 2026 $130 calls | Sweep | 70 | 7 | $42K | At ask | Bullish | High conviction |
| 21 Sep 2026 | INCY 19 Mar 2027 $120 calls | Sweep | 18 | 334 | $32K | At bid | Bearish | Notable |
| 22 Sep 2026 | INCY 18 Dec 2026 $105 calls | Trade | 10 | 329 | $26K | At ask | Bullish | |
| 25 Sep 2026 | INCY 15 Jan 2027 $130 calls | Trade | 26 | 361 | $25K | Above ask | Bullish |
Size above open interest means the trade opened a position larger than everything that existed in the contract the night before. Above ask and below bid are the most aggressive executions. Read the guide: Size versus open interest.
Where the money is aimed
| Expiry | Prints | Premium | Calls share | Net premium |
|---|---|---|---|---|
| 16 Oct 2026 | 1 | $66K | 100% | +$66K |
| 20 Nov 2026 | 1 | $42K | 100% | +$42K |
| 19 Mar 2027 | 1 | $32K | 100% | -$32K |
| 18 Dec 2026 | 1 | $26K | 100% | +$26K |
| 15 Jan 2027 | 1 | $25K | 100% | +$25K |
The most premium, $66K, is aimed at the 16 Oct 2026 expiry.
A print in a contract expiring this week is a view about the next few days, often about a known event; a print months out is a different kind of statement. Read the guide: 0DTE options flow.
The last session, 25 September 2026
| Date | Contract | Type | Size | Open int. | Premium | Execution | Sentiment | Tier |
|---|---|---|---|---|---|---|---|---|
| 25 Sep 2026 | INCY 20 Nov 2026 $130 calls | Sweep | 70 | 7 | $42K | At ask | Bullish | High conviction |
| 25 Sep 2026 | INCY 15 Jan 2027 $130 calls | Trade | 26 | 361 | $25K | Above ask | Bullish |
Every print in INCY with its full detail, the live tape, one tap filters and saved screeners: open INCY in Options Sentiment Screener.
Price
The live quote and the price chart sit beside the ticker's flow in the app: open INCY in Options Sentiment Screener.
Analysts
The most recent analyst targets on file, from 16 firms, have a median of $126, 2.1% above the last close.
Calls bought at a strike above the average target are a bet that the analysts are too cautious; puts far below the price in a name they like are protection or a strong disagreement. Read the guide: Reading one ticker's flow.
About Incyte Corp.
- Exchange
- Nasdaq
- Sector
- Health Care
- Industry
- Business Services
- Headquarters
- Wilmington, Delaware
- Website
- incyte.com
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD) It also develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
In the same sector
Flow pages for other Health Care names in the S&P 500:
LLY Eli Lilly & Co.JNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co. Inc.UNH UnitedHealth Group Inc.TMO Thermo Fisher Scientific Inc.AMGN Amgen Inc.GILD Gilead Sciences, Inc.
Learn
- What unusual options activity means
- Reading one ticker's flow
- Sweeps, blocks and where a trade printed
- Size versus open interest
- Bullish or bearish, how a print's sentiment is inferred
- The conviction score and whale prints
The live tape for INCY with every print's execution detail, one tap filters for calls, puts, sweeps and 0DTE, saved screeners and, for Realtime subscribers, push alerts and no delay. The same screen is in the iOS and Android apps.
Open INCY in Options Sentiment Screener